Amarin Corporation is a global pharmaceutical company that is dedicated to revolutionizing cardiovascular disease management and making a significant impact on patients' lives worldwide. With a bold vision to stop cardiovascular disease from being a leading cause of death, Amarin is relentlessly pursuing scientific breakthroughs and developing innovative therapeutics to improve cardiovascular health cost-effectively.
As a rapidly growing international leader in the fight against cardiovascular disease, Amarin is committed to creating a new paradigm in CVD management. With a global footprint, the company is making a positive impact on cardiovascular health across the world. Through its strategic approach to management and financial responsibility, Amarin aims to achieve its vision and ensure that cardiovascular disease is no longer a leading cause of death globally.
Generated from the website